Latest filing published 07 Feb 2018 for Soleno Therapeutics INC, €5,300.
Insider track record
Rajen Dalal: trading record in brief
Rajen Dalal discloses dealings in Soleno Therapeutics Inc to SEC (Form 4). In total, 5 filings cover trades dated from 23 January 2017 to 5 February 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 7 February 2018 came the latest disclosure, a share grant for €5,300 in Soleno Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 6 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Rajen Dalal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,813 shares@ US$1.7318.3% of flowCommon StockSEC:0000899243-18-003148:0
- 12,661 shares@ US$0.5219.3% of flowCommon StockSEC:0000899243-17-023569:0
- 10,793 shares@ US$0.6119.9% of flowCommon StockSEC:0000899243-17-018375:0
- 7,315 shares@ US$0.9021.2% of flowCommon StockSEC:0000899243-17-010274:0
- 10,450 shares@ US$0.6321.3% of flowCommon StockSEC:0000899243-17-010274:1
5 of 5 declarations
